Compare StocksJNJ vs MSCI

Johnson & Johnson (JNJ) vs MSCI Inc. (MSCI): Which Is the Better Buy in 2026?

As of 2026-09-17, JNJ is fairly valued at $269, with a DCF intrinsic value of $303 and a margin of safety of 11%. MSCI is overvalued at $545, with an intrinsic value of $463 and a margin of safety of -18%. Of the two, JNJ has the wider margin of safety.

JNJ
Johnson & Johnson
$269.35
VS
MSCI
MSCI Inc.
$545.36

Rewards

JNJ
  • Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 68.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
MSCI
  • MSCI Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 83.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • MSCI Inc. scores 99/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.

Risks

JNJ
  • FCF yield of 2.6% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 31.2x is 56% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • PEG ratio of 2.79 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
MSCI

    Key Valuation Metrics

    Learn more →
    JNJ
    MSCI
    Valuation
    $16.89B
    Free Cash Flow
    $1.19B
    2.60%
    FCF Yield
    3.01%
    31.21
    Trailing P/E
    30.03
    21.93
    Forward P/E
    24.24
    Quality & Moat
    16.85%
    ROIC
    22.66%
    25.74%
    ROE
    N/A
    68.14%
    Gross Margin
    82.97%
    2.79
    PEG Ratio
    1.88
    Balance Sheet Safety
    0.33
    Net Debt / Equity
    N/A
    N/A
    Interest Coverage
    N/A
    0.81
    Net Debt / EBITDA
    3.16
    2.01%
    Dividend Yield
    1.52%
    JNJ: 4Ties: 2MSCI: 4
    JNJMSCI

    Historical Fundamentals

    Learn more →
    JNJ

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    MSCI

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    JNJ
    $0.91
    created per $1 retained over 3 years
    Mediocre Allocator
    Σ Retained
    $40.05B
    Δ Market Cap
    +$36.63B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    MSCI
    $2.56
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $1.95B
    Δ Market Cap
    +$5.01B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    JNJ
    11.0% Margin of Safety
    Price is 11.0% below estimated fair value
    Current Price: $269.35
    Fair Value: $302.57
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    MSCI
    17.9% Overvalued
    Price is 17.9% above estimated fair value
    Current Price: $545.36
    Fair Value: $462.73
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    JNJ

    What growth rate is the market pricing in at $269?

    +9.8%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +17.2%

    The market implies +9.8% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +17.2%, reflecting heavy growth investment.

    MSCI

    What growth rate is the market pricing in at $545?

    +15.5%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +16.6%

    The market implies +15.5% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +16.6%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    JNJ
    90/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
    MSCI
    99/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    JNJ
    -2.31
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    MSCI
    -2.74
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    JNJ
    Insiders 0.1%Institutions 76.7%Retail & Other 23.2%
    No. of Institutional Holders5,826
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    MSCI
    Insiders 3.6%Institutions 95.7%Retail & Other 0.7%
    No. of Institutional Holders1,586
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    JNJ
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $257,688
    MORIKIS JOHN G
    Director
    $257,688
    @ $206.15 · 2025-11-26
    WEINBERGER MARK A
    Director
    $147,220
    @ $147.22 · 2024-12-12
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    MSCI
    1
    Buys (3M)
    5
    Buys (12M)
    Total value (12M): $15.51M
    TANEJA RAJAT
    Director
    $1.00M
    @ $560.00 · 2026-09-02
    FERNANDEZ HENRY A
    Chief Executive Officer
    $2.25M
    @ $562.40 · 2026-05-15
    ASHE ROBERT GERARD
    Director
    $2.00M
    @ $543.21 · 2026-02-18
    FERNANDEZ HENRY A
    Chief Executive Officer
    $3.56M
    @ $523.56 · 2026-02-17
    FERNANDEZ HENRY A
    Chief Executive Officer
    $6.70M
    @ $536.14 · 2025-12-05
    FERNANDEZ HENRY A
    Chief Executive Officer
    $6.73M
    @ $542.87 · 2025-07-25
    FERNANDEZ HENRY A
    Chief Executive Officer
    $3.04M
    @ $574.51 · 2025-02-24
    FERNANDEZ HENRY A
    Chief Executive Officer
    $1.78M
    @ $612.80 · 2024-12-05
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    JNJ
    6
    Sells (3M)
    15
    Sells (12M)
    Total value (12M): $132.73M
    SCHMID TIMOTHY
    Officer
    $9.23M
    @ $274.74 · 2026-09-02
    TAUBERT JENNIFER L
    Officer
    $3.95M
    @ $263.36 · 2026-08-17
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $32.20M
    @ $261.17 · 2026-08-13
    FORMINARD ELIZABETH
    Officer
    $4.09M
    @ $257.00 · 2026-08-06
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $12.52M
    @ $258.15 · 2026-08-05
    BROADHURST VANESSA
    Officer
    $5.79M
    @ $251.27 · 2026-07-20
    WENGEL KATHRYN E
    Chief Technology Officer
    $2.41M
    @ $241.15 · 2026-06-11
    DECKER ROBERT J
    Officer
    $1.01M
    @ $247.87 · 2026-02-27
    SCHMID TIMOTHY
    Officer
    $324,763
    @ $245.66 · 2026-02-20
    SCHMID TIMOTHY
    Officer
    $5.53M
    @ $244.33 · 2026-02-18
    REED JOHN C
    Officer
    $13.11M
    @ $243.00 · 2026-02-17
    WOLK JOSEPH J
    Chief Financial Officer
    $21.77M
    @ $242.80 · 2026-02-17
    SWANSON JAMES D
    Chief Technology Officer
    $15.11M
    @ $243.39 · 2026-02-17
    BROADHURST VANESSA
    Officer
    $1.51M
    @ $243.39 · 2026-02-17
    REED JOHN C
    Officer
    $4.19M
    @ $192.71 · 2025-10-17
    TAUBERT JENNIFER L
    Officer
    $10.04M
    @ $177.81 · 2025-09-04
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $22.55M
    @ $179.21 · 2025-08-22
    WOLK JOSEPH J
    Chief Financial Officer
    $2.98M
    @ $176.91 · 2025-08-15
    REED JOHN C
    Officer
    $3.13M
    @ $163.55 · 2025-07-17
    DECKER ROBERT J
    Officer
    $1.16M
    @ $165.88 · 2025-02-25
    SCHMID TIMOTHY
    Officer
    $62,928
    @ $156.15 · 2025-02-18
    WOLK JOSEPH J
    Chief Financial Officer
    $2.00M
    @ $153.89 · 2025-02-07
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    MSCI
    0
    Sells (3M)
    5
    Sells (12M)
    Total value (12M): $7.04M
    WIECHMANN ANDREW CRAIG
    Chief Financial Officer
    $272,052
    @ $604.56 · 2026-06-10
    MUNARI ALVISE J.
    Officer
    $5.92M
    @ $592.04 · 2026-04-24
    WIECHMANN ANDREW CRAIG
    Chief Financial Officer
    $252,000
    @ $560.00 · 2026-03-17
    WIECHMANN ANDREW CRAIG
    Chief Financial Officer
    $247,500
    @ $550.00 · 2025-12-11
    GUTOWSKI ROBERT J
    General Counsel
    $348,454
    @ $558.42 · 2025-11-24
    PETTIT CARROLL DOUGLAS BAER
    President
    $2.82M
    @ $563.62 · 2025-06-05
    PETTIT CARROLL DOUGLAS BAER
    President
    $2.76M
    @ $552.59 · 2025-05-05
    PETTIT CARROLL DOUGLAS BAER
    President
    $2.62M
    @ $524.25 · 2025-04-04
    PETTIT CARROLL DOUGLAS BAER
    President
    $2.84M
    @ $568.36 · 2025-03-05
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    JNJ
    FearGreed
    😏Greed(68/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    MSCI
    FearGreed
    😐Neutral(46/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    JNJ
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (68)
    MSCI
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (46)
    View JNJ Full AnalysisView MSCI Full Analysis

    Frequently Asked Questions: JNJ vs MSCI

    Is Johnson & Johnson or MSCI Inc. more undervalued in 2026?

    Based on our discounted cash flow model, JNJ trades at a 11.0% margin of safety (intrinsic value $303 vs. price $269), compared to MSCI's -17.9% margin of safety (intrinsic $463 vs. $545).

    Which stock has a wider economic moat, Johnson & Johnson or MSCI Inc.?

    MSCI scores 99/100 (Wide moat), while JNJ scores 90/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Which company has better free cash flow, Johnson & Johnson or MSCI Inc.?

    MSCI Inc. (MSCI) generates a 3.0% free cash flow yield, compared to Johnson & Johnson's 2.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Johnson & Johnson or MSCI Inc.?

    MSCI earns 22.7% ROIC versus JNJ's 16.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, Johnson & Johnson's or MSCI Inc.'s?

    MSCI's dividend earns a safety score of 94/100 (Very Safe), compared to JNJ's 79/100 (Safe). MSCI has raised its dividend for 3 consecutive years.